SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 of 15(d) of the
Securities Exchange Act of 1934
March 1, 1996
------------------------------------------------
Date of Report (date of earliest event reported)
CONTOUR MEDICAL, INC.
----------------------------------------------------
Exact name of Registrant as Specified in its Charter
Nevada 33-19938-LA 77-0163521
- --------------------------- --------------- ---------------------------
State or Other Jurisdiction Commission File IRS Employer Identification
of Incorporation Number Number
3340 Scherer Drive, St. Petersburg, Florida 33716
----------------------------------------------------------
Address of Principal Executive Offices, Including Zip Code
(813) 572-0089
--------------------------------------------------
Registrant's Telephone Number, Including Area Code
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.
On March 1, 1996, Contour Medical, Inc. acquired AmeriDyne
Corporation ("Ameridyne") through a merger with a newly formed, wholly-owned
subsidiary of the Company. The Company issued 352,018 shares of its Common
Stock and paid $250,000 to Scott F. Lockridge, the sole shareholder of
AmeriDyne, for his shares of AmeriDyne in the merger. The cash used in this
transaction came from the Company's working capital.
Ameridyne is a bulk medical supply company based in Jackson,
Tennessee which has annual sales of approximately $10 million.
Scott F. Lockridge will continue to serve as the President of
AmeriDyne which will opeate as a wholly-owned subsidiary of the Company. The
shares issued to Mr. Lockridge in the merger represent approximately 7.1% of
the shares of the Company's Common Stock now outstanding.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) FINANCIAL STATEMENTS OF BUSINESSES ACQUIRED. The financial
statements reuqired by Rule 3-05(b) of Regulation S-X are not yet available
and will be filed by amendment on or before May 16, 1996.
(b) PRO FORMA FINANCIAL INFORMATION. The pro forma financial
information required by Article 11 of Regulation S-X is not yet available, and
will be filed by amendment on or before May 16, 1996.
(c) EXHIBITS.
Exhibit 10. Agreement and Plan of Merger by and Among
Contour Medical, Inc., Contour Merger Sub, Inc.,
Scott F.Lockridge and AmeriDyne Corporation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
CONTOUR MEDICAL, INC.
Dated: March 13, 1996 By /s/ Gerald J. Flanagan
------------------------------------
Gerald J. Flanagan, President